| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |